ATE303820T1 - Verwendung von einem für einem anti-angiogenen faktor codierenden vektor zur behandlung von vaskularisation der hornhaut - Google Patents
Verwendung von einem für einem anti-angiogenen faktor codierenden vektor zur behandlung von vaskularisation der hornhautInfo
- Publication number
- ATE303820T1 ATE303820T1 AT00993688T AT00993688T ATE303820T1 AT E303820 T1 ATE303820 T1 AT E303820T1 AT 00993688 T AT00993688 T AT 00993688T AT 00993688 T AT00993688 T AT 00993688T AT E303820 T1 ATE303820 T1 AT E303820T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- angiogenic factor
- vector encoding
- vascularization
- cornea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2257—Prolactin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Eyeglasses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9916780A FR2803207B1 (fr) | 1999-12-30 | 1999-12-30 | Utilisation d'un vecteur comprenant un acide nucleique codant pour un facteur anti-angiogenique pour le traitement des neovascularisations corneennes |
US21769100P | 2000-07-12 | 2000-07-12 | |
PCT/FR2000/003653 WO2001049316A2 (fr) | 1999-12-30 | 2000-12-21 | Utilisation d'un vecteur comprenant un acide nucleique codant pour un facteur anti-angiogenique pour le traitement des neovascularisations corneennes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE303820T1 true ATE303820T1 (de) | 2005-09-15 |
Family
ID=26235200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00993688T ATE303820T1 (de) | 1999-12-30 | 2000-12-21 | Verwendung von einem für einem anti-angiogenen faktor codierenden vektor zur behandlung von vaskularisation der hornhaut |
Country Status (9)
Country | Link |
---|---|
US (1) | US20080107714A1 (de) |
EP (1) | EP1246642B1 (de) |
JP (1) | JP2004500369A (de) |
AT (1) | ATE303820T1 (de) |
AU (1) | AU2857401A (de) |
DE (1) | DE60022549T2 (de) |
DK (1) | DK1246642T3 (de) |
ES (1) | ES2245656T3 (de) |
WO (1) | WO2001049316A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070148225A1 (en) * | 2005-12-23 | 2007-06-28 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
JP4855782B2 (ja) * | 2006-01-13 | 2012-01-18 | 株式会社シード | 眼の遺伝子治療に用いられるハイドロゲル製眼用レンズ |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3710796A (en) * | 1971-05-14 | 1973-01-16 | C Neefe | Corneal drug delivery method |
US5800820A (en) * | 1989-01-10 | 1998-09-01 | Repligen Corporation | Methods and compositions for treatment of angiogenic diseases |
FR2702152B1 (fr) * | 1993-03-03 | 1995-05-24 | Inst Nat Sante Rech Med | Virus recombinants et leur utilisation en thérapie génique. |
US5827702A (en) * | 1994-10-31 | 1998-10-27 | Genentech, Inc. | Ocular gene therapy |
FR2731014B1 (fr) * | 1995-02-23 | 1997-03-28 | Rhone Poulenc Rorer Sa | Molecules d'adn, preparation et utilisation en therapie genique |
US5801146A (en) * | 1996-05-03 | 1998-09-01 | Abbott Laboratories | Compound and method for inhibiting angiogenesis |
JP2001526040A (ja) * | 1997-12-08 | 2001-12-18 | ベス イスラエル ディーコネス メディカル センター | ピヒア酵母発現系を用いる抗血管形成タンパク質:エンドスタチン、アンジオスタチンまたはレスチンの生産方法 |
-
2000
- 2000-12-21 AT AT00993688T patent/ATE303820T1/de active
- 2000-12-21 JP JP2001549683A patent/JP2004500369A/ja not_active Withdrawn
- 2000-12-21 DE DE60022549T patent/DE60022549T2/de not_active Expired - Lifetime
- 2000-12-21 AU AU28574/01A patent/AU2857401A/en not_active Abandoned
- 2000-12-21 ES ES00993688T patent/ES2245656T3/es not_active Expired - Lifetime
- 2000-12-21 DK DK00993688T patent/DK1246642T3/da active
- 2000-12-21 WO PCT/FR2000/003653 patent/WO2001049316A2/fr active IP Right Grant
- 2000-12-21 EP EP00993688A patent/EP1246642B1/de not_active Expired - Lifetime
-
2008
- 2008-01-14 US US12/013,638 patent/US20080107714A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001049316A3 (fr) | 2002-05-23 |
DK1246642T3 (da) | 2006-01-09 |
EP1246642B1 (de) | 2005-09-07 |
ES2245656T3 (es) | 2006-01-16 |
US20080107714A1 (en) | 2008-05-08 |
DE60022549D1 (de) | 2005-10-13 |
JP2004500369A (ja) | 2004-01-08 |
AU2857401A (en) | 2001-07-16 |
WO2001049316A2 (fr) | 2001-07-12 |
EP1246642A2 (de) | 2002-10-09 |
DE60022549T2 (de) | 2006-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59902314D1 (de) | Oligomerisiertes Organopolysiloxan-Cokondensat, dessen Herstellung und dessen Verwendung zur Behandlung von Oberflächen | |
ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
ATE333888T1 (de) | Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen | |
ATE230607T1 (de) | Verwendung von neurturin protein zur vorbeugung und behandlung von gehörverlust | |
DE69527847D1 (de) | Verwendung von anti-vegf-mitteln zur behandlung der endometriose | |
DE602004020657D1 (de) | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen | |
DE60122368D1 (de) | Verwendung von Gaboxadol zur Behandlung von premenstruelle Störung, postnatal Depression oder postmenopausal-bedingte-dysphorische Störung | |
ATE504600T1 (de) | Verwendung von antikörpern gegen tweak zur behandlung von schlaganfall | |
DE69939956D1 (de) | Verwendung von Myoblasten zur Herstellung eines Medikaments zur Behandlung der stressbedingten Harninkontinenz | |
DE602004021847D1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
DE60038458D1 (de) | Verwendung von polymerem material zur behandlung harter oberflächen | |
DE60219658D1 (de) | Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren | |
ATE370738T1 (de) | Verwendung von eplerenon zur behandlung von restenose | |
ATE303820T1 (de) | Verwendung von einem für einem anti-angiogenen faktor codierenden vektor zur behandlung von vaskularisation der hornhaut | |
ATE332688T1 (de) | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung | |
ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
ATE402694T1 (de) | Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz | |
DE69827387D1 (de) | Verwendung von pramipexol zur behandlung von restless-legs-syndrom | |
DE69924284D1 (de) | Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten | |
DE60213365D1 (de) | Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen | |
DE60228988D1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
ATE247956T1 (de) | Verwendung von modafinil zur herstellung eines arzneimittels zur behandlung von vigilanzstörungen im zusammenhang mit myopathien | |
DE69919578D1 (de) | VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten | |
ATE314066T1 (de) | Verwendung von buprenorphin zur therapie der harninkontinenz | |
ATE360425T1 (de) | Verwendung von quetiapin für die behandlung von kokain-abhängigkeit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1246642 Country of ref document: EP |